학술논문

Cellular architecture of human brain metastases
Document Type
article
Source
Cell. 185(4)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Immunology
Cancer
Stem Cell Research - Nonembryonic - Human
Neurosciences
Stem Cell Research
Brain Disorders
Aetiology
1.1 Normal biological development and functioning
Underpinning research
2.1 Biological and endogenous factors
Adult
Aged
Animals
Biomarkers
Tumor
Brain Neoplasms
Cell Cycle
Cell Line
Tumor
Cell Proliferation
Female
Genetic Variation
Humans
Immune Evasion
Lymphocyte Activation
Lymphocytes
Tumor-Infiltrating
Mice
Inbred BALB C
Mice
Nude
Middle Aged
Models
Biological
Myeloid Cells
Principal Component Analysis
RNA-Seq
Single-Cell Analysis
T-Lymphocytes
CyTOF
blood tumor barrier
human metastasis
metastasis-associated macrophages
metastasis-infiltrated T cells
metastatic niche
metastatic program
metastatic tumor cells
metastatic tumors
single cell
Biological Sciences
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Brain metastasis (BrM) is the most common form of brain cancer, characterized by neurologic disability and an abysmal prognosis. Unfortunately, our understanding of the biology underlying human BrMs remains rudimentary. Here, we present an integrative analysis of >100,000 malignant and non-malignant cells from 15 human parenchymal BrMs, generated by single-cell transcriptomics, mass cytometry, and complemented with mouse model- and in silico approaches. We interrogated the composition of BrM niches, molecularly defined the blood-tumor interface, and revealed stromal immunosuppressive states enriched with infiltrated T cells and macrophages. Specific single-cell interrogation of metastatic tumor cells provides a framework of 8 functional cell programs that coexist or anticorrelate. Collectively, these programs delineate two functional BrM archetypes, one proliferative and the other inflammatory, that are evidently shaped through tumor-immune interactions. Our resource provides a foundation to understand the molecular basis of BrM in patients with tumor cell-intrinsic and host environmental traits.